|
Orthologous residues
|
|
ezrin (human): T567‑p, ezrin (mouse): T567‑p, ezrin (rat): T567‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Disease tissue studied:
colorectal cancer, colorectal carcinoma
|
|
Relevant cell lines - cell types - tissues:
Ls174T (intestinal), W4
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
MST4 (human)
|
siRNA inhibition of enzyme, genetic knockout/knockin of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
doxycycline
|
|
|
|
increase
|
|
|
|
|
LKB1 (human)
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
|
Effect of modification (process):
cytoskeletal reorganization
|